ArticleJournal of pharmacy & bioallied sciences2024
A Comparative Study of Euthyroid and Primary Hypothyroid Patients in End Stage Renal Disease (ESRD) Undergoing Maintenance Hemodialysis (MHD) in a Tertiary Care Hospital in Salem, Tamil Nadu.
Article in Journal of pharmacy & bioallied sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Aim: Hypothyroidism significantly alters renal function. Still, there are few scientific studies on thyroid disorders and how it influences renal function. Recent research suggested hypothyroidism may lower the glomerular filtration rate. This study aimed to assess changes in renal function biochemical parameters in MHD patients with primary hypothyroidism. Methods: 132 patients with MHD participated in a prospective research who had untreated primary hypothyroidism and euthyroidism. Immunoassay was used to quantify thyroid-stimulating hormone (TSH), free thyroxine (fT Results: In comparison with euthyroid MHD patients with primary hypothyroid MHD patients have higher significant values of TSH, creatinine, SBP, DBP as 3.57 ± 1.15 vs 10.49 ± 6.40, 8.23 ± 2.40 vs 9.31 ± 2.49, 155.87 ± 5.84 vs 162 ± 6.82, 91.73 ± 6.14 vs 98.64 ± 6.28. The fT Discussion: Our study demonstrated that in primary hypothyroid patients due to increase of SBP and DBP glomerular feedback is increased as a result creatinine excretion decreased. So GFR decreased leads to decreased iodine clearance and can cause decreased synthesis of thyroid hormones leading to primary hypothyroidism in MHD patients. Conclusions: Thyroid dysfunction is linked to impaired kidney function, making it crucial for clinicians to understand this connection in patients with multiple myeloma (MHD), and monitoring creatinine is essential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.